Quanxiao Li

634 total citations
27 papers, 434 citations indexed

About

Quanxiao Li is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Quanxiao Li has authored 27 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Quanxiao Li's work include Immune Response and Inflammation (7 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Quanxiao Li is often cited by papers focused on Immune Response and Inflammation (7 papers), Immunotherapy and Immune Responses (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Quanxiao Li collaborates with scholars based in China, New Zealand and United States. Quanxiao Li's co-authors include Ailian Zhang, Meng Jin, Yang Yu, Limin Jin, Tianlei Ying, Yahui Liu, Lei You, Gang Yang, Taiping Zhang and Yupei Zhao and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Quanxiao Li

26 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quanxiao Li China 12 210 138 94 69 62 27 434
Shujuan Liang China 14 275 1.3× 71 0.5× 153 1.6× 86 1.2× 42 0.7× 27 565
Noureldien H. E. Darwish United States 14 246 1.2× 109 0.8× 75 0.8× 59 0.9× 18 0.3× 36 621
Mohammed A. Attia Egypt 8 183 0.9× 115 0.8× 132 1.4× 60 0.9× 29 0.5× 21 478
Lu Zhan China 12 139 0.7× 55 0.4× 58 0.6× 64 0.9× 43 0.7× 26 393
Akiko Miyamoto Japan 14 226 1.1× 197 1.4× 203 2.2× 42 0.6× 79 1.3× 29 655
Xiumei Yang China 10 207 1.0× 36 0.3× 77 0.8× 69 1.0× 63 1.0× 33 481
Zhenghua Zhang China 16 327 1.6× 91 0.7× 173 1.8× 147 2.1× 23 0.4× 63 715
Mohd M. Khan United States 12 322 1.5× 92 0.7× 197 2.1× 58 0.8× 36 0.6× 23 650
Maryam Darvish Iran 12 221 1.1× 59 0.4× 55 0.6× 81 1.2× 20 0.3× 33 431
Zohreh Hojati Iran 13 443 2.1× 125 0.9× 68 0.7× 141 2.0× 16 0.3× 71 706

Countries citing papers authored by Quanxiao Li

Since Specialization
Citations

This map shows the geographic impact of Quanxiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quanxiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quanxiao Li more than expected).

Fields of papers citing papers by Quanxiao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quanxiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quanxiao Li. The network helps show where Quanxiao Li may publish in the future.

Co-authorship network of co-authors of Quanxiao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Quanxiao Li. A scholar is included among the top collaborators of Quanxiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quanxiao Li. Quanxiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Quanxiao, Yu Kong, Ailing Huang, et al.. (2025). An IL-15-modified NKp30×HER2 trispecific NK cell engager enhances NK cell activation and tumor cell killing. Journal of Leukocyte Biology. 117(8).
2.
Huang, Keke, Yuqing Wu, Yu Kong, et al.. (2025). Topical delivery of a human single-domain antibody targeting IL-33 to inhibit mucosal inflammation. Cellular and Molecular Immunology. 22(8). 918–934. 2 indexed citations
3.
Cai, Huiyu, et al.. (2024). Pretrainable geometric graph neural network for antibody affinity maturation. Nature Communications. 15(1). 7785–7785. 12 indexed citations
4.
Li, Quanxiao, Meng Jin, Zhen Ding, et al.. (2024). Renal Clearable Nanodots‐Engineered Erythrocytes with Enhanced Circulation and Tumor Accumulation for Photothermal Therapy of Hepatocellular Carcinoma. Small. 20(25). e2309278–e2309278. 7 indexed citations
5.
Jin, Meng, et al.. (2024). Cell membrane-functionalized bismuth oxyiodide nanodots as potential contrast agent for gastrointestinal tract imaging. Colloids and Surfaces B Biointerfaces. 245. 114235–114235. 1 indexed citations
6.
Wang, Zhi, et al.. (2024). High-Affinity Fully Human Anti-EpCAM Antibody with Biased IL-2 Exhibits Potent Antitumor Activity. Biomolecules. 14(11). 1399–1399. 1 indexed citations
7.
Zhu, Xiaoyi, Quanxiao Li, Yu Kong, et al.. (2023). A novel human single-domain antibody-drug conjugate targeting CEACAM5 exhibits potent in vitro and in vivo antitumor activity. Acta Pharmacologica Sinica. 45(3). 609–618. 13 indexed citations
8.
Li, Quanxiao, Jun Lu, Jinyao Li, et al.. (2023). Antibody-based cancer immunotherapy by targeting regulatory T cells. Frontiers in Oncology. 13. 1157345–1157345. 24 indexed citations
9.
Li, Quanxiao, Meiyan Zhu, Yuhao Tang, et al.. (2022). A novel risk signature based on autophagy-related genes to evaluate tumor immune microenvironment and predict prognosis in hepatocellular carcinoma. Computers in Biology and Medicine. 152. 106437–106437. 2 indexed citations
10.
Zhao, Bing, et al.. (2022). Cultivated Artemisia rupestris L. polysaccharide CARP2 as an adjuvant for influenza vaccines to prolong immune responses. International Journal of Biological Macromolecules. 224. 713–724. 4 indexed citations
11.
Hu, Dan, Quanxiao Li, Chunyu Wang, et al.. (2022). Half-Life Extension Enhances Drug Efficacy in Adeno-Associated Virus Delivered Gene Therapy. Engineering. 21. 203–213. 2 indexed citations
12.
Shi, Yibing, Huifang Wu, Weiqiang Hu, et al.. (2022). An antigen-strengthened dye-modified fully-human-nanobody-based immunoprobe for second near infrared bioimaging of metastatic tumors. Biomaterials. 287. 121637–121637. 6 indexed citations
13.
Li, Quanxiao, et al.. (2022). Immunoregulatory properties of the cultivated Artemisia rupestris L. polysaccharide as a potential adjuvant. Carbohydrate Polymers. 291. 119525–119525. 10 indexed citations
14.
15.
Wu, Yanling, Quanxiao Li, Yu Kong, et al.. (2022). A highly stable human single-domain antibody-drug conjugate exhibits superior penetration and treatment of solid tumors. Molecular Therapy. 30(8). 2785–2799. 48 indexed citations
16.
Li, Quanxiao, Limin Jin, & Meng Jin. (2021). Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma. Frontiers in Genetics. 12. 613890–613890. 8 indexed citations
17.
Li, Quanxiao, Meng Jin, Yahui Liu, & Limin Jin. (2020). Gut Microbiota: Its Potential Roles in Pancreatic Cancer. Frontiers in Cellular and Infection Microbiology. 10. 572492–572492. 45 indexed citations
18.
Ricciardiello, Francesca, Gang Yang, Roberta Palorini, et al.. (2020). Hexosamine pathway inhibition overcomes pancreatic cancer resistance to gemcitabine through unfolded protein response and EGFR-Akt pathway modulation. Oncogene. 39(20). 4103–4117. 38 indexed citations
19.
20.
Li, Quanxiao, Gang Yang, Mengyu Feng, et al.. (2018). NF-κB in pancreatic cancer: Its key role in chemoresistance. Cancer Letters. 421. 127–134. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shujuan Liang Breakdown of academic impact, for papers by Noureldien H. E. Darwish Breakdown of academic impact, for papers by Mohammed A. Attia Breakdown of academic impact, for papers by Lu Zhan Breakdown of academic impact, for papers by Akiko Miyamoto Breakdown of academic impact, for papers by Xiumei Yang Breakdown of academic impact, for papers by Zhenghua Zhang Breakdown of academic impact, for papers by Mohd M. Khan Breakdown of academic impact, for papers by Maryam Darvish Breakdown of academic impact, for papers by Zohreh Hojati
Rankless by CCL
2026